Article
Fetal RHD genotyping is a cost-effective option for supporting targeted anti-D prophylaxis in D-negative pregnancies.
BJOG : an international journal of obstetrics and gynaecology - 1 Oct 2018
Allard S, Massey E
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
